HCS Group to Sell Oxo Business to Aeicon

03:58 EDT 26 Mar 2020 | CHEManager

HCS Group, a Germany-based global manufacturer of hydrocarbon and chemical specialty products, signed a definitive agreement to sell its US Oxo-product business to Aeicon, an investment firm based in Houston, TX, USA. The transaction includes the manufacturing site of HC Manvel in Manvel, TX, and is expected to close in Q3 2020. Financial details were not disclosed.

Original Article: HCS Group to Sell Oxo Business to Aeicon


More From BioPortfolio on "HCS Group to Sell Oxo Business to Aeicon"

Quick Search

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...